A Phase 2 interventional study of Ciclosporin in Periodontitis, sponsored by PerioC Limited. Completed at 1 site in Sweden. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2017-04-07.
Sponsored by PerioC Limited · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Periodontitis with a site in Sweden — 5 open to participants now, 6 under way, none of them phase 3. Periodontitis · Sweden.
Among the 10 studies in Periodontitis with a site in Sweden, this one is the only one that started in 2015, is the only one in phase 2, and was the 2nd registered.
1,235 studies on the registry are indexed under Periodontitis; 298 are open to participants now.
Browse Periodontitis studies →5 of the 10 studies in Periodontitis with a site in Sweden are open now. Recruiting first, the newest first:
Göteborg University · Sites in Sweden
Ages 18+
Karolinska Institutet · Sites in Sweden
Ages 18+
Ostergotland County Council, Sweden · Sites in Sweden
Ages 18+
Malmö University · Sites in Sweden
Ages 18–120
Folktandvården Stockholms län AB · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 160 Periodontitis studies recruiting now, 79 (49%) set no upper age limit and 60 (38%) stop at 75 or younger; 12 take children under 18; 77 take healthy volunteers.
This study: 30 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2015.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 23 is below the median of 44 across 848 interventional studies indexed under Periodontitis.
Median enrollment 87 across the 6 interventional studies, 210 across the 4 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 10 have an industry lead sponsor. The 9 most frequent:
This is the only study on the registry with PerioC Limited as lead sponsor.
PerioC Limited has 1 study filed under Periodontitis — fewer than ten, so there is no comparison to draw.
1 of the studies in Periodontitis with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07426224Folktandvården Stockholms län ABBlood Glucose Screening in Patients With Advanced Periodontits: the Role of Specialist Periodontal Care in Identifying Hyperglycaemia and Supporting Patient Centered Treatment | 2027-03-01 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Periodontitis with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The main purpose of the trial is to investigate the effect of locally delivered ciclosporin as an adjunct to non-surgical mechanical debridement in the treatment of chronic periodontitis and to compare it to mechanical debridement alone.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Treatment of two periodontal pockets with ciclosporin gel Non-treatment of two periodontal pockets in same patient as comparator
Drug: Ciclosporin
Ciclosporin gel applied to two periodontal pockets
Probing pocket depth (PPD)
Mean change in probing pocket depth (PPD) from baseline to 3-month examination
Time frame: 3 months
Bleeding on Probing (BoP)
Change in BoP (measured as present or absent) from baseline to 3-month examination
Time frame: 3 months
The record gives a start of Mar 2015, a primary completion of Sep 2016 and a completion of Oct 2016. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Cyclosporine